Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-004572

Director sold 15,000 shares at $11.87 ($178,089)

From the SEC's structured data for this filing

Trades in this filing

Gould Robert J · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Sale : show line 1 in the form −15,000 $11.87 $178,089 469,864 D
Open-market sales · 15,000 sh · avg $11.87 · $178,089
Loading xslF345X05/ownership.xml…